Cardiology

New research suggests Abbott's HeartMate 3 could revolutionize preimplantation strategy by eliminating use of categories based on transplant eligibility.

Less than 1 in 4 eligible Medicare patients attend a cardiac rehabilitation program and, among participants, adherence to programs remains an issue.

Investigators find an association between fetuses with congenital heart disease and impaired fetal hippocampal and cerebellar development.

A recent analysis of ARIC study data found burnout is associated with a 1.45-fold increased risk of developing the cardiac condition.

Despite it being the preferred treatment in guidelines, ticagrelor was linked with more major bleeding and dyspnea than clopidogrel.

Approval of Aidoc's AI package could improve diagnosis and subsequent outcomes for stroke in emergency departments.

An expecting mother's use of antihypertensive medication may affect their risk of having a preterm birth, new findings show.

An analysis of more than 9000 patients found incident heart disease was associated with an increased risk of developing kidney failure later in life.

A new study has found habitual tea drinkers lowered their risk of atherosclerotic cardiovascular disease, coronary heart disease, and stroke compared to never or non-habitual tea drinkers.

An analysis of the CARDIA study revealed BMI in young adulthood served as a better predictor of obesity up to 25 years in the future than polygenic risk scores.

A recent study found a lower blood pressure target in older adults could reduce risk of cardiovascular events and death, but could negatively impact kidney function.

Abbot announced early Tuesday morning that the US FDA has granted approval for the HeartMate 3 device to be implanted via a lateral thoracotomy for patients with advanced heart failure.

A new study examining rates of venous thromboembolism revealed children receiving PICCs as opposed to CVCs were at an increased risk of blood clots.

A new study from George Mason University is offering additional insight into the impact of e-cigarette and combustible cigarette use on a person's risk of stroke.

The tweet chat returns for a special crossover collaboration with a popular health data organization.

The U.S. Food and Drug Administration has approved an omega-3 fatty acid treatment as an add-on treatment to statin therapy to reduce the risk of cardiovascular disease in adults with elevated triglyceride levels.

The U.S. Food and Drug Administration has approved an omega-3 fatty acid treatment as an add-on treatment to statin therapy to reduce the risk of cardiovascular disease in adults with elevated triglyceride levels.

A study from investigators at UCLA has identified a biomarker investigators suggest can help identify stable heart failure patients at an increased risk of death within the next 3 years.

A recent study examining 140 Australians found alcohol abstinence reduced the recurrence and burden of atrial fibrillation in regular drinkers between the ages of 18 and 85 years old.

Increased levels of pyrethroid insecticide exposure was linked to increased in all-cause mortality, as well as increases in mortality from cancer and cardiovascular disease in a recent study from the University of Iowa.

New research shows that abstaining from alcohol can reduce the occurrence of irregular or abnormal heart rhythms in adults with atrial fibrillation who are moderate consumers of alcohol.

A recent study from the Mayo Clinic of Rochester, MN is suggested diabetes mellitus is an independent risk factor for the development of heart failure.

A look back at the developments and interviews that caught the most attention this year.

How the two critical specialties become better bridged at medical meetings?

What the current critical care team looks like, and how it could be bettered.

TAVR has revolutionized treatment for aortic stenosis but we are still learning more about how to best manage antithrombotic strategy following this procedure.

With a shortage of hearts available, investigators turn to HCV-positive donors to try to reduce wait times.

A recent study from McMaster University has revealed NT-proBNP levels could serve as a predictor of cardiac injury after noncardiac procedures.

The US FDA has announced the approval of 2 applications for apixaban—marking the first generic approval of a direct oral anticoagulant.

Findings of a systematic review showed that traffic-related air pollution can lead to hypertensive disorders and cardiovascular events for pregnant women.